Binding of ApoE Isoforms to Aβ Peptides and Effects on Their Fibrillization
Open Access
- 3 February 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (6) , 10626-10631
Abstract
Alzheimer’s disease (AD) is the most widespread neurodegenerative disease, strongly linked to amyloid depositions in the brain consisting of amyloid β (Aβ) peptides. The likelihood of developing late-onset Alzheimer’s disease (LOAD) is influenced by the specific isoforms of apolipoprotein E (ApoE), with ApoE4 being the strongest known genetic risk factor for LOAD. Strong evidence suggests that ApoE impacts AD by modulating Aβ aggregation and clearance, although the precise molecular mechanisms remain incompletely understood. Microscale thermophoresis (MST) is a powerful technique for characterizing molecular interactions in solution, which has been used to determine various binding constants, although not the binding of ApoE to Aβ peptides. MST results show that ApoE isoforms bind Aβ1–40 and Aβ1–42 with low micromolar affinity. For Aβ1–42, ApoE3 shows the strongest binding (K d = 0.72 μM) and ApoE4 shows the weakest binding (K d = 2.80 μM). For Aβ1–40, ApoE4 shows the strongest binding (K d = 1.59 μM) and ApoE2 shows the weakest binding (K d = 5.29 μM). The MST results show that ApoE interacts with Aβ peptides at supraphysiological peptide concentrations. However, ApoE inhibited the fibrillization of Aβ1–42 peptide at substoichiometric concentrations, which might be related to blocking Aβ fibril elongation in vivo. The estimated IC50 values indicate that ApoE4 has a slightly stronger, and ApoE2 a slightly weaker, inhibitory effect on Aβ1–42 fibrillization.Keywords
All Related Versions
Funding Information
- Hj?rnfonden
- Eesti Teadusagentuur (PRG 1289)
This publication has 39 references indexed in Scilit:
- The LDL Receptor-Related Protein 1: Mechanisms and roles in promoting Aβ efflux transporter in Alzheimer’s diseaseBiochemical Pharmacology, 2024
- Microscale thermophoresis (MST) and spectral shift (SpS) in drug discoveryTrAC Trends in Analytical Chemistry, 2024
- APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s diseaseSeminars in Immunology, 2022
- Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral SclerosisChemical Reviews, 2021
- Real-Time Analysis of Specific Binding between Apolipoprotein E Isoforms and Amyloid β-Peptide by Dual Polarization InterferometryAnalytical Chemistry, 2020
- APOE-amyloid interaction: Therapeutic targetsNeurobiology of Disease, 2020
- The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid AggregationBiochemistry, 2014
- Cu(II) Affinity for the Alzheimer’s Peptide: Tyrosine Fluorescence Studies RevisitedAnalytical Chemistry, 2012
- A Synthetic Peptide Blocking the Apolipoprotein E/β-Amyloid Binding Mitigates β-Amyloid Toxicity and Fibril Formation in Vitro and Reduces β-Amyloid Plaques in Transgenic MiceThe American Journal of Pathology, 2004
- Higher avidity binding of apolipoprotein (E–AII) complex than of apolipoprotein E monomer to β‐amyloidJournal of Neuroscience Research, 1999